Most not too long ago, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to the wide array of endogenous opioids. As opposed to most opioid receptors, this receptor https://coling874npq5.blogoscience.com/profile